Harbour Trust & Investment Management Co Sells 527 Shares of Colgate-Palmolive Company $CL

Harbour Trust & Investment Management Co trimmed its position in shares of Colgate-Palmolive Company (NYSE:CL) by 3.5% during the 2nd quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The fund owned 14,555 shares of the company’s stock after selling 527 shares during the quarter. Harbour Trust & Investment Management Co’s holdings in Colgate-Palmolive were worth $1,323,000 as of its most recent filing with the Securities and Exchange Commission.

Several other large investors have also recently added to or reduced their stakes in CL. Westend Capital Management LLC grew its stake in Colgate-Palmolive by 111.1% during the first quarter. Westend Capital Management LLC now owns 266 shares of the company’s stock worth $25,000 after buying an additional 140 shares during the last quarter. Cornerstone Planning Group LLC grew its stake in Colgate-Palmolive by 1,913.3% during the first quarter. Cornerstone Planning Group LLC now owns 302 shares of the company’s stock worth $28,000 after buying an additional 287 shares during the last quarter. Saudi Central Bank acquired a new position in shares of Colgate-Palmolive during the first quarter worth approximately $29,000. Ransom Advisory Ltd bought a new stake in shares of Colgate-Palmolive during the first quarter valued at approximately $33,000. Finally, Harel Insurance Investments & Financial Services Ltd. bought a new position in Colgate-Palmolive in the 1st quarter worth approximately $37,000. 80.41% of the stock is owned by institutional investors.

Colgate-Palmolive Price Performance

Shares of CL stock opened at $76.99 on Tuesday. Colgate-Palmolive Company has a 52-week low of $76.68 and a 52-week high of $102.61. The stock has a market cap of $62.22 billion, a PE ratio of 21.63, a PEG ratio of 4.29 and a beta of 0.34. The company has a debt-to-equity ratio of 6.79, a quick ratio of 0.57 and a current ratio of 0.89. The firm’s 50 day moving average price is $82.44 and its two-hundred day moving average price is $87.73.

Colgate-Palmolive (NYSE:CL) last announced its quarterly earnings data on Friday, August 1st. The company reported $0.92 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $0.89 by $0.03. Colgate-Palmolive had a net margin of 14.55% and a return on equity of 377.63%. The firm had revenue of $5.11 billion for the quarter, compared to analysts’ expectations of $5.03 billion. During the same period last year, the firm earned $0.91 earnings per share. The business’s revenue for the quarter was up 1.0% on a year-over-year basis. As a group, analysts forecast that Colgate-Palmolive Company will post 3.75 EPS for the current year.

Colgate-Palmolive Announces Dividend

The company also recently announced a quarterly dividend, which will be paid on Friday, November 14th. Shareholders of record on Friday, October 17th will be issued a $0.52 dividend. The ex-dividend date is Friday, October 17th. This represents a $2.08 annualized dividend and a yield of 2.7%. Colgate-Palmolive’s dividend payout ratio (DPR) is 58.43%.

Wall Street Analyst Weigh In

Several research analysts have issued reports on the company. The Goldman Sachs Group reduced their price objective on Colgate-Palmolive from $106.00 to $91.00 and set a “buy” rating on the stock in a report on Thursday, October 2nd. JPMorgan Chase & Co. reduced their price objective on Colgate-Palmolive from $95.00 to $88.00 and set an “overweight” rating on the stock in a report on Friday. Weiss Ratings reaffirmed a “hold (c)” rating on shares of Colgate-Palmolive in a report on Wednesday, October 8th. UBS Group reduced their price objective on Colgate-Palmolive from $99.00 to $92.00 and set a “buy” rating on the stock in a report on Wednesday, October 8th. Finally, Bank of America reduced their price objective on Colgate-Palmolive from $98.00 to $88.00 and set a “buy” rating on the stock in a report on Wednesday, October 8th. Eight analysts have rated the stock with a Buy rating, five have issued a Hold rating and one has issued a Sell rating to the stock. Based on data from MarketBeat, the company presently has a consensus rating of “Moderate Buy” and an average price target of $92.21.

About Colgate-Palmolive

Colgate-Palmolive Company, together with its subsidiaries, manufactures and sells consumer products in the United States and internationally. It operates through two segments: Oral, Personal and Home Care; and Pet Nutrition. The Oral, Personal and Home Care segment offers toothpaste, toothbrushes, mouthwash, bar and liquid hand soaps, shower gels, shampoos, conditioners, deodorants and antiperspirants, skin health products, dishwashing detergents, fabric conditioners, household cleaners, and other related items.